TOBRAMYCIN

Product NDC: 61919-224
11-digit product format: 619190224
Labeler code: 61919
Product ID: 61919-224_5ed44f2b-d396-4d73-91af-98aa4cf22966
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: TOBRAMYCIN
Dosage form: SOLUTION
Route: ORAL
Labeler: Direct Rx
Application: ANDA064052
Marketing category: ANDA
Marketing start: 2014-01-01
Marketing end: 0000-00-00
Substance: TOBRAMYCIN
Active strength: 3 mg/mL
Pharmacologic classes: Aminoglycoside Antibacterial [EPC],Aminoglycosides [CS]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	61919-224		I	Inactivated by FDA		2026-08-11
excluded package	package	61919-224	61919-224-05	I	Inactivated by FDA		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61919-224-05	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61919-224-05	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61919-224-05	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61919-224-05	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61919-224-05	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61919-224-05	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61919-224-05	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61919-224-05	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61919-224-05	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61919-224-05	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61919-224-05	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61919-224-05	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	61919-224-05	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	61919-224-05	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	61919-224-05	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	61919-224-05	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	61919-224-05	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	61919-224-05	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	61919-224-05	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	61919-224-05	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	61919-224-05	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	61919-224-05	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A064052-001	TOBRAMYCIN	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT		1993-11-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A064052-001	AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A064052-001	TOBRAMYCIN	0.3%	SOLUTION/DROPS / OPHTHALMIC	AT	1993-11-29	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A064052-001	AT	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A064052-001	AT	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A064052-001	AT	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A064052-001	AT	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A064052-001	AT	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A064052-001	AT	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A064052-001	AT	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A064052-001	AT	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A064052-001	AT	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A064052-001	AT	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A064052-001	AT	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A064052-001	AT	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A064052-001	AT	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A064052-001	AT	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A064052-001	AT	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A064052-001	AT	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A064052-001	AT	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A064052-001	AT	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A064052-001	AT	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A064052-001	AT	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A064052-001	AT	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A064052-001	AT	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A064052-001	AT	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A064052-001	AT	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A064052-001	AT	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A064052-001	AT	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A064052-001	AT	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A064052-001	AT	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A064052-001	AT	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A064052-001	AT	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A064052-001	AT	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A064052-001	AT	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A064052-001	AT	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A064052-001	AT	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A064052-001	AT	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A064052-001	AT	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A064052-001	AT	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A064052-001	AT	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A064052-001	AT	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A064052-001	AT	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f297c7c1-845a-4369-8c02-c51b92d6ae8e	Product name	3	20240725
551d952d-4ce2-24f0-9ab0-630ad9aae596	Product name	2	20231211
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
941f67d9-7f03-56d2-750c-36de24f654db	Product name	3	20221117
9cfa145f-dbe9-bc02-83c2-692786ef6676	Product name	9	20210928
2f9713b8-5e7e-bbcc-b364-1b2c27a63796	Product name	4	20210903
32a533bc-01c7-2b9f-bbf7-ecfb0d964277	Product name	4	20210625
9f5124fb-08b0-4c3e-8e12-a1a6ff310cba	Product name	1	20150309
745a62af-e1c0-4ca3-6d6e-2b6455b903be	Product name	1	20140508
9ea85abb-fa68-5da6-ab60-2c7eef579000	Product name	1	20140508
aa1cd319-ece7-51f7-3a9d-52a64f5f4e81	Product name	1	20140508
d029211e-5e6b-725f-3696-ac6ff77da222	Product name	1	20140508
ef5b7aed-2b01-3ba8-5a1c-3bc9c9f03bb1	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61919-224-05	2020-01-31	C162847	48780-1	9d75b9d0-44e6-f424-e053-dadaa90a57ce	TOBRAMYCIN

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
61919-224-05	TOBRAMYCIN	1 mL in 1 CARTON	SOLUTION	1		3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61919-224-05	ML - Milliliter	61919-224	8998b3ad-c8ec-4413-bbe1-0cf0ca4da430	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
TOBRAMYCIN	ACTIVE INGREDIENT	VZ8RRZ51VK	TOBRAMYCIN SOLUTION [DIRECT RX]	3
TOBRAMYCIN	ACTIVE MOIETY	VZ8RRZ51VK	TOBRAMYCIN SOLUTION [DIRECT RX]	3
BENZALKONIUM CHLORIDE	INACTIVE INGREDIENT	F5UM2KM3W7	TOBRAMYCIN SOLUTION [DIRECT RX]	3
BORIC ACID	INACTIVE INGREDIENT	R57ZHV85D4	TOBRAMYCIN SOLUTION [DIRECT RX]	3
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	TOBRAMYCIN SOLUTION [DIRECT RX]	3
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	TOBRAMYCIN SOLUTION [DIRECT RX]	3
SODIUM SULFATE	INACTIVE INGREDIENT	0YPR65R21J	TOBRAMYCIN SOLUTION [DIRECT RX]	3
SULFURIC ACID	INACTIVE INGREDIENT	O40UQP6WCF	TOBRAMYCIN SOLUTION [DIRECT RX]	3
TYLOXAPOL	INACTIVE INGREDIENT	Y27PUL9H56	TOBRAMYCIN SOLUTION [DIRECT RX]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	TOBRAMYCIN SOLUTION [DIRECT RX]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61919-224	TOBRAMYCIN SOLUTION [DIRECT RX]	3	Legacy NDC, 1 package rows	20150504_bcf3ba10-6ee8-45ed-abbe-329a18e5d192.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tobramycin	TOBRAMYCIN	Preferred Pharmaceuticals Inc.	417623f1-ed48-41f5-a4b4-6f2e4a23891e	2026-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 064052 application number: ANDA064052
Tobramycin	TOBRAMYCIN	Sportpharm LLC	6ded47a3-d5c0-4616-8b7d-d6d0e6bce2a0	2026-02-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 064052 application number: ANDA064052
Tobramycin	TOBRAMYCIN	Advanced Rx Pharmacy of Tennessee, LLC	fc734c2d-0d45-195c-e053-6394a90a2a92	2024-12-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 064052 application number: ANDA064052
Tobramycin	TOBRAMYCIN	NuCare Pharmaceuticals,Inc.	58b1fa9d-a302-6dc6-e053-2991aa0a3741	2024-08-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 064052 application number: ANDA064052
Tobramycin	TOBRAMYCIN	Asclemed USA, Inc.	c6f9c6b1-2c45-4f6b-a1fb-e55d74fc04c3	2024-03-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 064052 application number: ANDA064052
Tobramycin	TOBRAMYCIN	Bausch & Lomb Incorporated	a5693ec9-d2f7-4d45-90b0-a113c54840d7	2023-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 064052 application number: ANDA064052
Tobramycin	TOBRAMYCIN	A-S Medication Solutions	774b608b-d6d9-4349-8772-11c69897be42	2023-05-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 064052 application number: ANDA064052
Tobramycin	TOBRAMYCIN	Proficient Rx LP	d8235017-cb52-44d4-a6e6-6ee3f00c47d2	2022-07-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 064052 application number: ANDA064052

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
VZ8RRZ51VK	TOBRAMYCIN	32986-56-4	TOBRAMYCIN

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
61919-224-05	61919022405	1 mL in 1 CARTON	1 ml	Historical